Summary
(All regions of Colombia)
IQVIA Oncology Dynamics (Colombia), established in 2020, contains complete patient oncology treatment information collected directly from physicians via a web-based questionnaire. It is an oncology-specific database with drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.
The database is updated twice a year and has diagnosis, drug, and procedure data. To date it has close to 7,000 patients.
The Colombian dataset is a part of the IQVIA Oncology Dynamics portfolio. The full portfolio is a global database comprising patient records spanning 22 countries:
- Australia
- Austria
- Belgium
- Brazil
- Bulgaria
- China
- Colombia
- Czech Republic
- France
- Germany
- India
- Italy
- Japan
- Mexico
- Romania
- Saudi Arabia
- Slovakia
- South Korea
- Spain
- Turkey
- United Kingdom
- USA
IQVIA Oncology Dynamics (Colombia), established in 2020, contains complete patient oncology treatment information collected directly from physicians via a web-based questionnaire. It is an oncology-specific database with drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.
(Survey-based, i.e., complete patient oncology treatment information is collected directly from physicians via a web questionnaire.)
(Twice a year)
The database consists of drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.
The database consists of drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.
The IQVIA Oncology Dynamics (Colombia) database is updated twice a year.
This profile was developed for the B.R.I.D.G.E. TO DATA site on September 10, 2025.
Population Dynamics
There are a total of 6,843 patients to date
There are a total of 775 active oncology drug-treated patients
(Not applicable)
The sample is not weighted in any way. It is meant to give a representative view of the treated prevalent cancer population.
(Not applicable, as data collection is still ongoing)
Demographic Data
N/A
(Not available; please contact database manager for information)
N/A
(Not available; please contact database manager for information)
Ethnicity/race data are not collected
All areas of Colombia
(Year)
(Not applicable)
Physician & Practioner Info
(Not applicable)
Diagnoses/Signs & Symptoms
(Only one - primary cancer diagnosis is listed)
This is an oncology-specific database with drug-treated patients with one of the following (cancer) indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.
(This information is not available; please contact the database manager for details.)
Procedures
Information on drug treatment is available
Drug Information
Data are available on: Treatment dates, molecule level, brand name, posology or daily dose, length of prescription, side effects/adverse events, reason for discontinuation of treatment, cycles planned vs. given; duration of prior line of therapy
Data are available on treatment dates
(This information is not available - please contact database manager.)
Brand name is available
Posology or daily dose information is available
Information is available on length of prescription
(Not applicable)
(This information is not available; please contact the database manager for details.)
Information is available on:
- Side effects/adverse events
- Reason for discontinuation of treatment
- Cycles planned vs. given
- Duration of prior line of therapy
- Molecule level
Biobanks
Genetic-PGx Data
Economic Data
(Not applicable)
(Not applicable)
(Not applicable)
Validation & Linkage
However, numerous quality checks are performed on the data collected to ensure accuracy
Linkage does exist
All Oncology Dynamics databases are linked; however, they are not linked to other IQVIA Health databases. Please contact database manager for details.
Administrative Information
Email: RWDassets@iqvia.com
N/A
(Not applicable)
(IQVIA)
(Not applicable)
N/A
(Not applicable)
This is a subscription database available to the pharmaceutical industry. Interested clients should contact email RWDassets@iqvia.com for more information regarding access.
Please email database contact mentioned above regarding costs related to any project or direct query
Aggregated reports (excel, ppt, flatfiles, etc.)
Local BI software
Publications are pending. Please contact IQVIA for more information.
Publications are pending. Please contact IQVIA for more information.
Database Contact
Email: RWDassets@iqvia.com
N/A
Literature References
Publications are pending. Please contact IQVIA for more information.